Clinical Trial Update: Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on cyclophosphamide for chronic fatigue syndrome/myalgic encephalomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Chronic Fatigue Syndrome (CFS), Myalgic Encephalomyelitis (ME) | Phase 2 | Status: COMPLETED